Statements of Cash Flows - USD ($)
|
6 Months Ended |
12 Months Ended |
Dec. 31, 2015 |
Dec. 31, 2016 |
| Cash Flows from Operating Activities: |
|
|
| Net loss |
$ (116,505)
|
$ (653,234)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Cash held in trust account, interest income available for taxes |
|
(691,951)
|
| Accrued interest income |
(25,377)
|
(139,749)
|
| Changes in operational assets and liabilities: |
|
|
| Prepaid expenses |
(17,800)
|
(12,725)
|
| Accounts payable and accrued expenses |
76,454
|
111,837
|
| Net cash used in operating activities |
(83,228)
|
(1,385,822)
|
| Cash Flows from Investing Activities: |
|
|
| Proceeds released from Trust |
|
124,482
|
| Cash held in Trust Activity |
(325,000,000)
|
|
| Net cash provided (used in) investment activities |
(325,000,000)
|
124,482
|
| Cash Flows from Financing Activities: |
|
|
| Proceeds from notes payable to related parties |
280,000
|
500,000
|
| Repayments of notes payable to related parties |
(280,000)
|
|
| Proceeds from issuance of common stock to initial stockholders |
25,000
|
|
| Proceeds from sale of Units, net underwriter commissions paid |
317,665,553
|
|
| Proceeds from issuance of Sponsors' warrants |
8,250,000
|
|
| Net cash provided by financing activities |
325,940,553
|
500,000
|
| Net (Decrease) Increase in cash and cash equivalents |
857,325
|
(761,340)
|
| Cash and cash equivalents, beginning of period |
|
857,325
|
| Cash and cash equivalents, end of period |
857,325
|
95,985
|
| Supplemental disclosure of non-cash investing and financing activities: |
|
|
| Initial value of common stock subject to redemption |
309,564,545
|
|
| Change in value of common stock subject to redemption |
(115,498)
|
(653,234)
|
| Deferred underwriter fee |
$ 11,375,000
|
|